One of the main challenges in managing NiV is the lack of specific antiviral treatments or vaccines. Additionally, the virus's ability to infect a wide range of hosts and its potential for human-to-human transmission complicates control measures. Limited healthcare infrastructure in affected regions can also hinder effective management of outbreaks.
